| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8776755 | The Breast | 2018 | 8 Pages |
Abstract
Four HADM products, AlloDerm-RTU, FD AlloDerm, AlloMax, and DermACELL, showed similar risks of complications. However since most of the included studies had a low level of evidence, further random trials with large numbers of patients are needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Li-Hong Wu, Min-Xia Zhang, Chun-Ye Chen, Qing-Qing Fang, Xiao-Feng Wang, Wei-Qiang Tan,